The global ADC contract manufacturing market was valued at USD 11.10 Million in 2024, driven by the rising prevalence of cancer across the globe. The market is expected to grow at a CAGR of 12.70% during the forecast period of 2025-2034, with the values likely to reach USD 36.69 Million by 2034.
Base Year
Historical Year
Forecast Year
Value in USD Million
2025-2034
ADC Contract Manufacturing Market Outlook
*this image is indicative*
ADC contract manufacturing organizations (CMOs) manage intricate procedures like conjugation, drug payload synthesis, and antibody production, guaranteeing that ADCs are produced to exact specifications. By using external facilities and expertise for large-scale production, this service helps pharmaceutical companies cut costs and accelerate time-to-market. To meet both commercial and regulatory demands, companies without internal capabilities must use ADC contract manufacturing.
The market is primarily aided by the growing number of regulatory approvals for ADCs granted by agencies such as the FDA and EMA. Simplified approval procedures for ADCs promote more development because of their potential to fill medical needs that aren't being met. Businesses are investing in ADCs with greater assurance as regulations become more favourable and clearer. Hence, driving the business opportunity for ADC contract manufacturing.
Rising Investments in Biotechnology to Drive Market Growth
The market growth is accelerated by increased funding for biotechnology and ADC-related research from the public and private sectors. Innovation in biopharmaceutics encourages the creation of new ADC products and production capacities. This capital inflow helps established businesses as well as startups grow their ADC pipelines, thereby, bolstering the market's growth during the forecast period.
The market is witnessing several trends and developments to improve the current global scenario. Some of the notable trends are as follows:
The report offers a detailed analysis of the market based on the following segments:
Market Breakup by Linker:
Market Breakup by Application:
Market Breakup by Region:
The Cleavable Segment Holds a Significant Market Share
The market segmentation by linker is divided into cleavable linker and non-cleavable linker. Precise delivery is ensured by cleavable linkers in ADCs, which are chemical bonds that release the drug payload inside target cancer cells. These intricate linkers, which need to be produced with extreme precision for efficient drug release, are the specialty of ADC contract manufacturers. Consequently, cleavable linkers are expected to lead the market share in the forecast period.
Regionally, North America is expected to dominate the market during the forecast period. This can primarily be ascribed to the rise in the prevalence of cancer and autoimmune diseases along with the growth in the geriatric population in the region. The United States dominated the market in North America in 2021 owing to factors such as a high patient pool for major chronic diseases. Additionally, over the forecast period, the presence of major players, early adoption of technologically advanced products, and an increase in research and development activities are expected to propel regional growth in the market.
The key features of the market report comprise the patent analysis, grants analysis, funding and investment analysis, and strategic initiatives by the leading key players. The major companies in the market are as follows:
Founded in 2011, Samsung Biologics is a top contract development and manufacturing organization (CDMO) with a focus on biopharmaceuticals, with its headquarters located in Incheon, South Korea. The company uses cutting-edge facilities and biologics knowledge to provide a wide range of services, including ADC contract manufacturing. It provides end-to-end solutions from development to commercial-scale production, which benefits multinational pharmaceutical companies.
It is a global leader in contract manufacturing and development services, with a focus on biologics, including ADCs. It was founded in 1897 and has its headquarters in Basel, Switzerland. The business provides comprehensive ADC production solutions that address large-scale manufacturing, conjugation, and drug development. With its state-of-the-art technologies and knowledge, Lonza helps biopharma companies effectively bring sophisticated ADC therapies to market.
*Please note that this is only a partial list; the complete list of key players is available in the full report. Additionally, the list of key players can be customized to better suit your needs.*
Other key players in the market include Catalent, Inc., Siegfried Holding AG, Piramal Pharma Limited, Sartorius AG, WuXi Biologics, and Sterling Pharma Solutions Limited (PMDO) among others.
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.
| REPORT FEATURES | DETAILS |
| Base Year | 2024 |
| Historical Period | 2018-2024 |
| Forecast Period | 2025-2034 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Linker |
|
| Breakup by Application |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
Datasheet
One User
USD 3,299
USD 2,969
tax inclusive*
Single User License
One User
USD 5,499
USD 4,949
tax inclusive*
Five User License
Five User
USD 6,999
USD 5,949
tax inclusive*
Corporate License
Unlimited Users
USD 8,199
USD 6,969
tax inclusive*
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Small Business Bundle
Growth Bundle
Enterprise Bundle
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
How To Order
Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Australia
63 Fiona Drive, Tamworth, NSW
+61-448-061-727
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-723-689-1189
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.
+63-287-899-028, +63-967-048-3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
United States
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84-865-399-124
United States (Head Office)
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Australia
63 Fiona Drive, Tamworth, NSW
+61-448-061-727
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-723-689-1189
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City, 1226.
+63-287-899-028, +63-967-048-3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84-865-399-124
Share